VAERS Explorer
Back to explore

Report #2844848

Received Jun 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
16 yrs
State
CA
Recovered
Unknown
Vaccinated
Jun 9, 2025
Onset
Jun 9, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
YFYELLOW FEVER (YF-VAX)SANOFI PASTEURUNKUK134AAOT / LA

Symptoms (2)

No adverse eventProduct preparation error

Symptom narrative

received a medication error with the YF-VAX was mixed with the incorrect diluent of sterile water, with no reported adverse event; Initial information received on 11-Jun-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 16 years old female patient who received Yellow fever vaccine - [YF-VAX] that was mixed with the incorrect diluent of sterile water, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 09-Jun-2025, the patient received a 0.5ml dose of suspect Yellow fever vaccine - Solution for injection standard strength (lot UK134AA) frequency once (expiry date-unknown) via intramuscular route in the left arm for Immunization and the vaccine was mixed with the incorrect diluent of sterile water, with no reported adverse event (product preparation error) (latency-same day). Reportedly- 2-consumers received a medication error with the YF-VAX and the consumers are family members. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.